CVRx, Inc. Common Stock
Symbol: CVRX (NASDAQ)
6.88
▲ (8.44%) 0.535
Company Description:
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Key Stats
- Today's Open: $6.21
- Today's High: $6.89
- Today's Low: $6.125
- Today's Volume: 399.84K
- Yesterday Close: $6.34
- Yesterday High: $6.52
- Yesterday Low: $6.0021
- Yesterday Volume: 529.26K
- Last Min Volume: 100
- Last Min High: $6.875
- Last Min Low: $6.875
- Last Min VWAP: $6.875
Company Profile
- Name: CVRx, Inc. Common Stock
- Website: https://www.cvrx.com
- Listed Date: 2021-06-30
- Location: MINNEAPOLIS, MN
- Market Status: Active
- CIK Number: 0001235912
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $123.84M
- Round Lot: 100
- Outstanding Shares: 26.07M
- Asset Type: CS
RECENT FILINGS FOR CVRX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-05-19 | 4 | View |
| 2025-05-14 | 4 | View |
| 2025-05-13 | 4 | View |
| 2025-05-12 | 4 | View |
| 2025-05-09 | 10-Q | View |
| 2025-05-08 | 8-K | View |
| 2025-04-23 | DEFA14A | View |
| 2025-04-23 | DEF 14A | View |
| 2025-04-07 | 8-K | View |
| 2025-03-04 | 4 | View |
| 2025-03-04 | 4 | View |
| 2025-03-04 | 4 | View |
| 2025-03-04 | 4 | View |
| 2025-03-04 | 4 | View |
| 2025-02-20 | SCHEDULE 13D/A | View |
| 2025-02-18 | S-8 | View |
| 2025-02-18 | 10-K | View |
| 2025-02-14 | 3 | View |
| 2025-02-06 | SCHEDULE 13D/A | View |
| 2025-02-06 | SCHEDULE 13G/A | View |
Latest News on CVRX